Galmed Pharmaceuticals (EOCN) Net Equity Issued and Repurchased (2014 - 2025)
Galmed Pharmaceuticals' Net Equity Issued and Repurchased came in at $7.5 million for Q4 2025.
Powered by 
Analysis
Galmed Pharmaceuticals (EOCN) Net Equity Issued and Repurchased (2014 - 2025) Analysis & Trends
For FY2025, Galmed Pharmaceuticals' Net Equity Issued and Repurchased was $7.67 million, up 74.9% from FY2024.
- Net Equity Issued and Repurchased carries a five-year compound annual growth rate of 163.0% (FY2020 to FY2025).
- Going back by year, Net Equity Issued and Repurchased was $4.39 million in FY2024 (-29.1%), $6.19 million in FY2023, $70,000 in FY2022 (-99.1%) and $8.15 million in FY2021.
- The Q4 2025 figure represents the highest quarterly Net Equity Issued and Repurchased since Q4 2017.
- Business Quant data shows EOCN's Net Equity Issued and Repurchased at $99,000 (Q3 2025), -$1.36 million (Q2 2025) and $1.44 million (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Galmed Pharmaceuticals | 406,071.97 | 406,071.97 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 7.50 Mn |
| Sep 30, 2025 | 99,000.00 |
| Jun 30, 2025 | -1.36 Mn |
| Mar 31, 2025 | 1.44 Mn |
| Mar 31, 2020 | 61,000.00 |
| Dec 31, 2019 | 48,000.00 |
| Jun 30, 2019 | 21,000.00 |
| Mar 31, 2019 | 74,000.00 |
| Dec 31, 2018 | 31,000.00 |
| Sep 30, 2018 | -46,000.00 |
| Jun 30, 2018 | 79.15 Mn |
| Mar 31, 2018 | 12,000.00 |
| Dec 31, 2017 | 14.70 Mn |
| Sep 30, 2017 | 66,000.00 |
| Dec 31, 2016 | 4.22 Mn |
| Sep 30, 2016 | 244,000.00 |
| Mar 31, 2014 | 2.00 Mn |
API Access
Galmed Pharmaceuticals Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=EOCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "EOCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=EOCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();